Murat Telli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Murat Telli has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Barış Akcan
Department of Pediatrics, Division of Neonatology Aydın Adnan Menderes University Faculty of Medicine Aydın Turkey
1 shared publication - Arzu İlKi̇
Faculty of Medicine, Department of Medical Microbiology, Marmara University , İstanbul, Turkey
1 shared publication - Atiye Meltem Aksoy1 shared publication
- Aylin Eryılmaz
Adnan Menderes Univ, Dept Otorhinolaryngol, Fac Med, Aydin, Turkey
1 shared publication - Aynur Eren Topkaya
Yeditepe Univ, Fac Med, Dept Med Microbiol, Istanbul, Turkey
1 shared publication - Ayşe Anık
Department of Pediatrics, Division of Neonatology Aydın Adnan Menderes University Faculty of Medicine Aydın Turkey
1 shared publication
Latest Publications
- Open Access
- 10 July 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Epidemiology, microbiological profile, and antimicrobial resistance patterns of culture-proven neonatal sepsis in a tertiary NICU
Neonatal sepsis remains a major cause of morbidity and mortality, particularly among preterm and low-birth-weight infants requiring prolonged neonatal inte
- 10 July 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Open AccessEpidemiology, microbiological profile, and antimicrobial resistance patterns of culture-proven neonatal sepsis in a tertiary NICU
Neonatal sepsis remains a major cause of morbidity and mortality, particularly among preterm and low-birth-weight infants requiring prolonged neonatal inte
- 25 March 2026
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 74 (1) , 1-8
Can tuberculosis and non-tuberculosis mycobacteria infections be differentiated radiologically?
Tuberculosis (TB) and non-tuberculous mycobacteria (NTM) are socioeconomically important infectious diseases. Diagnosis is supported by radiological examinations following the evaluation of clinical symptoms. Definitive diagnosis is made microbiologically or histopathologically. TB and NTM infections progress with different radiological findings such as cavitary and nodular infiltrations. In our study, it was aimed to investigate which criteria are stronger radiological determinants of which disease in microbiologically positive TB and NTM cases. In our study, 417 cases that were positive for TB and NTM infections in the five-year microbiology laboratory were evaluated. The symptoms, sociodemographic, laboratory and radiological findings of the cases were obtained retrospectively from epicrisis information. Patients with NTM growth were examined according to ATS/IDSA NTM Infection diagnostic criteria. There was a male sex predominance in both groups, and mean age was similar between the groups. The TB group was observed to present with more systemic symptoms, while the NTM group presented with more pulmonary symptoms. In radiological evaluation, the most common findings in both groups were nodules, consolidation, cavitation, and lymphadenopathy. The appearance of a tree in bud was also a common radiological finding in the TB group. When the two groups were compared, the presence of emphysema and atelectasis was significantly higher in the NTM group. In the diagnosis of TB and NTM infections, after taking a detailed anamnesis, care should be taken especially in terms of NTM infections in patients with radiological parenchymal damage.
- 25 March 2026
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 74 (1) , 1-8
Can tuberculosis and non-tuberculosis mycobacteria infections be differentiated radiologically?
Tuberculosis (TB) and non-tuberculous mycobacteria (NTM) are socioeconomically important infectious diseases. Diagnosis is supported by radiological examinations following the evaluation of clinical symptoms. Definitive diagnosis is made microbiologically or histopathologically. TB and NTM infections progress with different radiological findings such as cavitary and nodular infiltrations. In our study, it was aimed to investigate which criteria are stronger radiological determinants of which disease in microbiologically positive TB and NTM cases. In our study, 417 cases that were positive for TB and NTM infections in the five-year microbiology laboratory were evaluated. The symptoms, sociodemographic, laboratory and radiological findings of the cases were obtained retrospectively from epicrisis information. Patients with NTM growth were examined according to ATS/IDSA NTM Infection diagnostic criteria. There was a male sex predominance in both groups, and mean age was similar between the groups. The TB group was observed to present with more systemic symptoms, while the NTM group presented with more pulmonary symptoms. In radiological evaluation, the most common findings in both groups were nodules, consolidation, cavitation, and lymphadenopathy. The appearance of a tree in bud was also a common radiological finding in the TB group. When the two groups were compared, the presence of emphysema and atelectasis was significantly higher in the NTM group. In the diagnosis of TB and NTM infections, after taking a detailed anamnesis, care should be taken especially in terms of NTM infections in patients with radiological parenchymal damage.
- Open Access
- 30 December 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Comparing machine learning models for rule-out prediction of sexually transmitted infections in male patients: a retrospective study using urinalysis and symptom data
Introduction: Sexually transmitted infections (STIs) are a major public health issue, and prompt diagnosis is crucial for controlling infections. Multiplex PCR-based nucleic acid amplification tests (NAATs) are the gold standard for diagnosis, especially for identifying pathogens involved in gonococcal and nongonococcal urethritis. However, their frequent use in low-risk or asymptomatic men increases laboratory workload and healthcare expenses. Material and methods: This study employed machine learning algorithms to develop and validate a rule-out model designed to reduce unnecessary NAAT requests. Data from 2020 to 2024 (n = 455) were used for model training, and data from 2025 (n = 75) served as an external temporal test set. Model thresholds were optimized to ensure high sensitivity (≥ 95%) and a high negative predictive value (NPV ≥ 90%), emphasizing patient safety and reducing the risk of false negatives. The selected rule-out threshold (0.079) represented the lowest predicted-probability cut-point achieving these safety criteria and was applied to the independent test cohort. Data were collected from our institutional database. Five supervised models – XGBoost, logistic regression (LR), support vector machine (SVM), k-nearest neighbors (KNN), and random forest – were built and assessed. Results: XGBoost achieved the best rule-out performance (AUC = 0.86; sensitivity = 0.98; NPV = 0.91) while safely deferring NAAT testing in 44.2% of patients. Urinary WBC, leukocyte esterase, and nitrite were the strongest positive predictors, whereas absence of inflammation and asymptomatic presentation favored test deferral. Conclusions: This model can assist clinicians in identifying male patients likely to test negative on NAATs, supporting diagnostic stewardship through cost-effective, data-driven decision-making.
- 30 December 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Open AccessComparing machine learning models for rule-out prediction of sexually transmitted infections in male patients: a retrospective study using urinalysis and symptom data
Introduction: Sexually transmitted infections (STIs) are a major public health issue, and prompt diagnosis is crucial for controlling infections. Multiplex PCR-based nucleic acid amplification tests (NAATs) are the gold standard for diagnosis, especially for identifying pathogens involved in gonococcal and nongonococcal urethritis. However, their frequent use in low-risk or asymptomatic men increases laboratory workload and healthcare expenses. Material and methods: This study employed machine learning algorithms to develop and validate a rule-out model designed to reduce unnecessary NAAT requests. Data from 2020 to 2024 (n = 455) were used for model training, and data from 2025 (n = 75) served as an external temporal test set. Model thresholds were optimized to ensure high sensitivity (≥ 95%) and a high negative predictive value (NPV ≥ 90%), emphasizing patient safety and reducing the risk of false negatives. The selected rule-out threshold (0.079) represented the lowest predicted-probability cut-point achieving these safety criteria and was applied to the independent test cohort. Data were collected from our institutional database. Five supervised models – XGBoost, logistic regression (LR), support vector machine (SVM), k-nearest neighbors (KNN), and random forest – were built and assessed. Results: XGBoost achieved the best rule-out performance (AUC = 0.86; sensitivity = 0.98; NPV = 0.91) while safely deferring NAAT testing in 44.2% of patients. Urinary WBC, leukocyte esterase, and nitrite were the strongest positive predictors, whereas absence of inflammation and asymptomatic presentation favored test deferral. Conclusions: This model can assist clinicians in identifying male patients likely to test negative on NAATs, supporting diagnostic stewardship through cost-effective, data-driven decision-making.
- 23 October 2023
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 57 (4) , 507-534
The Change in Antimicrobial Resistance During the COVID-19 Pandemic in Türkiye
Antimicrobial resistance (AMR) is one of the most important problems threatening human health worldwide. The impact of the Coronavirus disease-2019 (COVID-19) pandemic on AMR continues to be discussed. Some researchers argue that the pandemic will increase AMR rates, while others suggest the opposite. The aim of this study was to investigate the change in AMR of Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus strains in three cross-sectional periods in Turkiye, the first one before the COVID-19 pandemic, the second and the third one during the pandemic. The change in antibiotic susceptibility in Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus strains isolated from urine, blood, and lower respiratory tract samples of patients hospitalized in intensive care units and wards of hospitals before (November 2019) and during the COVID-19 pandemic (November 2020 and July 2021) was investigated in this study. A total of 17 voluntary hospitals, members of the Antibiotic Sus- ceptibility Surveillance Study Group (ADSI) of the Society for Clinical Microbiology Specialists (KLIMUD), participated in the study. Identification of bacteria was performed with automated bacterial identification systems (VITEK2, bioMerieux, France or Phoenix, BD, USA). Antibiotic susceptibility tests were performed in one center with the Kirby-Bauer disc diffusion method and in other centers with automated antibi- otic susceptibility test systems (VITEK2, bioMerieux, France or Phoenix, BD, USA), and the results were evaluated according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. Antibiotic susceptibility ratios were statistically analyzed using either the chi-square or Fisher's exact test. A p-value of < 0.05 was considered statistically significant. Antibiotic susceptibility test results of a total of 4030 strains; 1152, 1139, and 1739 belonging to November 2019, November 2020, and July 2021, respectively; were examined. While cefotaxime and ceftazidime susceptibility rates in E.coli strains increased during the pandemic period compared to previous period (p= 0.04, p= 0.001, respectively); nitrofurantoin sensitivity (p= 0.02) and extended-spectrum beta-lactamase (ESBL) ratios (p< 0.001) were found to be decreased. It was determined that the susceptibility rates of all other examined antimicrobials did not change statistically. It was observed that the susceptibility rates of all antibiotics in K.pneumoniae isolates decreased during the pandemic period, but the ESBL rates increased between 2019-2020 (p= 0.01) and decreased between 2020-2021 (p= 0.02). It was found that ESBL rates increased before and after the pandemic. It was observed that the susceptibility to ciprofloxacin (p= 0.0001), levofloxacin (p= 0.003), and gentamicin (p= 0.005) in S.aureus strains increased during the pandemic period. No significant changes were observed in other antibiotic susceptibility rates. Methicillin resistance of S.aureus (MRSA) strains decreased between 2019-2020 (p= 0.03) and increased again in 2021 (p= 0.04) and returned to the pre-pandemic rate. Our study results suggest that the measures taken to reduce the spread of COVID-19 with the pandemic (such as quarantine practices, increased hand hygiene, mask use, and national/international travel restriction) may reduce the spread of bacteria such as ESBL-producing E.coli and the rate of MRSA, which is considered as a hand hygiene indicator. The increase in the later stages of the pandemic recalls the relaxation in compliance with hand hygiene rules. The decrease in the susceptibility rate of K.pneumoniae isolates to antibiotics and the increase in the ESBL rate may be due to inappropriate and excessive use of antibiotics during the pandemic period. However, we believe that these data should be supported by studies to be conducted nowadays when all the rules and measures are back as if the pandemic has ended.
- 23 October 2023
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 57 (4) , 507-534
The Change in Antimicrobial Resistance During the COVID-19 Pandemic in Türkiye
Antimicrobial resistance (AMR) is one of the most important problems threatening human health worldwide. The impact of the Coronavirus disease-2019 (COVID-19) pandemic on AMR continues to be discussed. Some researchers argue that the pandemic will increase AMR rates, while others suggest the opposite. The aim of this study was to investigate the change in AMR of Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus strains in three cross-sectional periods in Turkiye, the first one before the COVID-19 pandemic, the second and the third one during the pandemic. The change in antibiotic susceptibility in Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus strains isolated from urine, blood, and lower respiratory tract samples of patients hospitalized in intensive care units and wards of hospitals before (November 2019) and during the COVID-19 pandemic (November 2020 and July 2021) was investigated in this study. A total of 17 voluntary hospitals, members of the Antibiotic Sus- ceptibility Surveillance Study Group (ADSI) of the Society for Clinical Microbiology Specialists (KLIMUD), participated in the study. Identification of bacteria was performed with automated bacterial identification systems (VITEK2, bioMerieux, France or Phoenix, BD, USA). Antibiotic susceptibility tests were performed in one center with the Kirby-Bauer disc diffusion method and in other centers with automated antibi- otic susceptibility test systems (VITEK2, bioMerieux, France or Phoenix, BD, USA), and the results were evaluated according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. Antibiotic susceptibility ratios were statistically analyzed using either the chi-square or Fisher's exact test. A p-value of < 0.05 was considered statistically significant. Antibiotic susceptibility test results of a total of 4030 strains; 1152, 1139, and 1739 belonging to November 2019, November 2020, and July 2021, respectively; were examined. While cefotaxime and ceftazidime susceptibility rates in E.coli strains increased during the pandemic period compared to previous period (p= 0.04, p= 0.001, respectively); nitrofurantoin sensitivity (p= 0.02) and extended-spectrum beta-lactamase (ESBL) ratios (p< 0.001) were found to be decreased. It was determined that the susceptibility rates of all other examined antimicrobials did not change statistically. It was observed that the susceptibility rates of all antibiotics in K.pneumoniae isolates decreased during the pandemic period, but the ESBL rates increased between 2019-2020 (p= 0.01) and decreased between 2020-2021 (p= 0.02). It was found that ESBL rates increased before and after the pandemic. It was observed that the susceptibility to ciprofloxacin (p= 0.0001), levofloxacin (p= 0.003), and gentamicin (p= 0.005) in S.aureus strains increased during the pandemic period. No significant changes were observed in other antibiotic susceptibility rates. Methicillin resistance of S.aureus (MRSA) strains decreased between 2019-2020 (p= 0.03) and increased again in 2021 (p= 0.04) and returned to the pre-pandemic rate. Our study results suggest that the measures taken to reduce the spread of COVID-19 with the pandemic (such as quarantine practices, increased hand hygiene, mask use, and national/international travel restriction) may reduce the spread of bacteria such as ESBL-producing E.coli and the rate of MRSA, which is considered as a hand hygiene indicator. The increase in the later stages of the pandemic recalls the relaxation in compliance with hand hygiene rules. The decrease in the susceptibility rate of K.pneumoniae isolates to antibiotics and the increase in the ESBL rate may be due to inappropriate and excessive use of antibiotics during the pandemic period. However, we believe that these data should be supported by studies to be conducted nowadays when all the rules and measures are back as if the pandemic has ended.
- Open Access
- 22 April 2021
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rhinology and Allergy
- Vol. 4 (1) , 16-20
Microbiological Factors and Inflammatory Cytokines in Acute and Chronic Rhinosinusitis
Acute rhinosinusitis,chronic rhinosinusitis,inflammation,microbiology,pathophysiology
- 22 April 2021
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rhinology and Allergy
- Vol. 4 (1) , 16-20
Open AccessMicrobiological Factors and Inflammatory Cytokines in Acute and Chronic Rhinosinusitis
Acute rhinosinusitis,chronic rhinosinusitis,inflammation,microbiology,pathophysiology
- Open Access
- 6 May 2020
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 20 (3) , 247-250
An Adolescent with a Suddenly Developed Mask Face
- 6 May 2020
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 20 (3) , 247-250
Open AccessAn Adolescent with a Suddenly Developed Mask Face
- 1 April 2019
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 20 (1) , 51-56
Seropositivity of Bartonella henselae in Risky Human Population, Cats and Dogs
- 1 April 2019
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 20 (1) , 51-56
Seropositivity of Bartonella henselae in Risky Human Population, Cats and Dogs
- Open Access
- 1 October 2015
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 59 (10) , 6657-6660
Identification of NDM-1 in a Putatively Novel Acinetobacter Species (“NB14”) Closely Related to Acinetobacter pittii
In this study, we describe the molecular characterization of a plasmid-located bla NDM-1 harbored by an Acinetobacter clinical isolate recovered from a patient in Turkey that putatively constitutes a novel Acinetobacter species, as shown by its distinct ARDRA (amplified 16S ribosomal DNA restriction analysis) profile and molecular sequencing techniques. bla NDM-1 was carried by a conjugative plasmid widespread among non- baumannii Acinetobacter isolates, suggesting its potential for dissemination before reaching more clinically relevant Acinetobacter species.
- 1 October 2015
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 59 (10) , 6657-6660
Open AccessIdentification of NDM-1 in a Putatively Novel Acinetobacter Species (“NB14”) Closely Related to Acinetobacter pittii
In this study, we describe the molecular characterization of a plasmid-located bla NDM-1 harbored by an Acinetobacter clinical isolate recovered from a patient in Turkey that putatively constitutes a novel Acinetobacter species, as shown by its distinct ARDRA (amplified 16S ribosomal DNA restriction analysis) profile and molecular sequencing techniques. bla NDM-1 was carried by a conjugative plasmid widespread among non- baumannii Acinetobacter isolates, suggesting its potential for dissemination before reaching more clinically relevant Acinetobacter species.